The Food and Drug Administration approved a new nonhormonal oral drug Friday, under the brand name Veozah, designed to treat menopausal hot flashes.The drug provides women with a safe and effective treatment option, Dr. Janet Maynard, director of the F.D.A. Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine said in a statement.
#people #effectively #researchers #productivity #availability #black-women #clinical-trials #groundbreaking #insurance-companies #health-conditions
[
add
]
[
|
|
...
]